Sellas Life Sciences Group
(NASDAQ) SLS
Sellas Life Sciences Group Financials at a Glance
Market Cap
$678.02M
Revenue (TTM)
$0.00
Net Income (TTM)
$26.86M
EPS (TTM)
$-0.25
P/E Ratio
-19.36
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$5.24
Volume
125,825
Open
$4.91
Price
$5.24
Volume
125,825
Open
$4.91
Previous Close
$4.76
Daily Range
$4.91 - $5.47
52-Week Range
$0.95 - $6.14
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$5.24
Volume
125,825
Open
$4.91
Previous Close
$4.76
Daily Range
$4.91 - $5.47
52-Week Range
$0.95 - $6.14
SLS News
SLS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sellas Life Sciences Group
Industry
Biotechnology
Sector
Health CareEmployees
13
CEO
Angelos M. Stergiou, MD
Website
www.sellaslifesciences.comHeadquarters
New York City, NY 10036, US
SLS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-67%
Return on Capital
-40%
Return on Assets
-34%
Earnings Yield
-5.17%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$678.02M
Shares Outstanding
142.44M
Volume
125.83K
Short Interest
0.00%
Avg. Volume
9.26M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$28.27M
EBITDA
$28.27M
Operating Cash Flow
$28.39M
Capital Expenditure
$0.00
Free Cash Flow
$28.39M
Cash & ST Invst.
$71.89M
Total Debt
$1.00M
Sellas Life Sciences Group Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$678.02M
N/A
Market Cap/Employee
$45.20M
N/A
Employees
15
N/A
Net Income
$7.66M
-13.7%
EBITDA
$8.26M
+49.6%
Quarterly Fundamentals
Net Cash
$70.89M
+450.2%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$457.00K
+0.0%
Short Term Debt
$544.00K
+0.0%
Return on Assets
-34.29%
N/A
Return on Invested Capital
-39.64%
N/A
Free Cash Flow
$4.92M
+31.2%
Operating Cash Flow
$4.92M
+31.2%